Vertex (VRTX) EVP/CMO Carmen Bozic Sells 1,745 Shares

What Happened
Carmen Bozic, Executive Vice President and Chief Medical Officer at Vertex Pharmaceuticals (VRTX), sold 1,745 shares on 2026-06-05 at $450.00 per share for a total of $785,250. The transaction was a sale (S) reported on a Form 4.

Key Details

• Transaction date: 2026-06-05; reported (filed) on 2026-06-09 (filed within required reporting window).
• Price and amount: 1,745 shares at $450.00 per share; proceeds = $785,250.
• Post-transaction holdings: Not specified in the information provided in this summary (not disclosed here).
• Footnote: Transaction was made pursuant to a company-approved Rule 10b5-1 trading plan entered 2025-11-20 (pre-arranged sale).
• Transaction type noted as open-market or private sale in the filing.

Context

• Sales executed under a pre-established 10b5-1 plan are common and typically reflect scheduled, pre-authorized trading rather than a contemporaneous change in insider sentiment.
• This was a straightforward sale of shares (not an option exercise, gift, or award).